HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hendrik Luesch Selected Research

Laxaphycin A

1/2018Discovery of new A- and B-type laxaphycins with synergistic anticancer activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hendrik Luesch Research Topics

Disease

42Neoplasms (Cancer)
01/2022 - 01/2002
8Breast Neoplasms (Breast Cancer)
01/2021 - 08/2010
7Colonic Neoplasms (Colon Cancer)
01/2022 - 03/2010
4Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 11/2011
4Neoplasm Metastasis (Metastasis)
01/2021 - 09/2017
3Triple Negative Breast Neoplasms
01/2021 - 11/2017
3Hypoxia (Hypoxemia)
10/2018 - 01/2016
3Neuroblastoma
04/2013 - 03/2007
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2019
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 01/2008
2Lung Diseases (Lung Disease)
01/2016 - 02/2013
2Adenocarcinoma
08/2015 - 09/2010
2Carcinoma (Carcinomatosis)
08/2015 - 09/2010
2Inflammation (Inflammations)
09/2013 - 02/2013
1Starvation
10/2021
1Noncommunicable Diseases
09/2021
1Pathologic Neovascularization
08/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Colitis
01/2020
1Opioid-Related Disorders (Opiate Addiction)
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Brain Neoplasms (Brain Tumor)
01/2020
1Central Nervous System Diseases (CNS Diseases)
01/2020
1Choroidal Neovascularization
01/2019
1Retinal Neovascularization
01/2019
1Infections
10/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018

Drug/Important Bio-Agent (IBA)

8largazoleIBA
08/2021 - 11/2010
7Biological ProductsIBA
01/2021 - 04/2012
5Pharmaceutical PreparationsIBA
10/2017 - 01/2011
4Histone Deacetylases (Histone Deacetylase)IBA
08/2021 - 11/2010
4Phosphotransferases (Kinase)IBA
10/2020 - 07/2009
4Pancreatic Elastase (Elastase)IBA
01/2020 - 02/2013
4Peptide Hydrolases (Proteases)FDA Link
07/2018 - 01/2016
3Histone Deacetylase InhibitorsIBA
08/2021 - 11/2010
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2011
3apratoxin S10IBA
01/2019 - 10/2017
3tyrosine receptor (receptor, tyrosine)IBA
01/2019 - 07/2009
3Histones (Histone)IBA
08/2014 - 11/2010
3apratoxin AIBA
11/2011 - 06/2008
2ChromatinIBA
01/2022 - 03/2011
2LuciferasesIBA
01/2022 - 03/2007
2Proteasome Endopeptidase Complex (Proteasome)IBA
09/2021 - 01/2018
2DepsipeptidesIBA
08/2021 - 02/2013
2apratoxin S4IBA
01/2021 - 01/2019
2TubulinIBA
01/2021 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2008
2Sulfhydryl Compounds (Thiols)IBA
01/2020 - 01/2017
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2020
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 11/2011
2Small Interfering RNA (siRNA)IBA
10/2018 - 11/2017
2Anti-Bacterial Agents (Antibiotics)IBA
10/2018 - 01/2016
2Cysteine (L-Cysteine)FDA Link
11/2017 - 06/2008
2CathepsinsIBA
11/2017 - 01/2016
2dolastatin 10IBA
03/2015 - 01/2002
2symplostatin 1IBA
03/2015 - 04/2003
2quinone (benzoquinone)IBA
04/2013 - 03/2007
2Oxidoreductases (Dehydrogenase)IBA
04/2013 - 03/2007
2NAD (NADH)IBA
04/2013 - 03/2007
2Sunitinib (Sutent)FDA Link
09/2011 - 01/2011
2Bevacizumab (Avastin)FDA Link
09/2011 - 01/2011
2Sorafenib (BAY 43-9006)FDA Link
09/2011 - 01/2011
1Carboxylic AcidsIBA
03/2022
1dysidazirineIBA
03/2022
1IronIBA
10/2021
1AlkaloidsIBA
09/2021
1aaptamineIBA
09/2021
1homoserine lactoneIBA
01/2021
1AndrogensIBA
01/2021
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2020
1ProdrugsIBA
01/2020
1dolastatin 15IBA
01/2020
1VincamineIBA
01/2020
1CalciumIBA
01/2020
1Yohimbine (Yocon)IBA
01/2020
1LipocalinsIBA
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1CytokinesIBA
01/2019
1Oxygen (Dioxygen)IBA
01/2019
1Thiamine (Aneurin)FDA Link
10/2018
1Kallikreins (Kallikrein)IBA
07/2018
1Serine Proteases (Serine Protease)IBA
07/2018
1Dihydrotachysterol (AT 10)IBA
07/2018
1Cardiac GlycosidesIBA
01/2018
1molassamideIBA
01/2018
1UbiquitinIBA
01/2018
1Peptides (Polypeptides)IBA
01/2018
1Laxaphycin AIBA
01/2018
1Plasminogen Activator Inhibitor 1IBA
11/2017
1Biomarkers (Surrogate Marker)IBA
11/2017
1Cystatin CIBA
11/2017
1grassystatin FIBA
11/2017
1Cathepsin DIBA
11/2017
1Protease Inhibitors (Protease Inhibitor)IBA
11/2017
1Interleukin-6 (Interleukin 6)IBA
10/2017
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2017

Therapy/Procedure

11Therapeutics
01/2022 - 11/2010
2Drug Therapy (Chemotherapy)
01/2021 - 01/2018
1Lasers (Laser)
01/2019